5+

Sri Krishna Pharmaceuticals Limited (SKPL), established in 1974, pioneering the manufacture of ACETAMINOPHEN (PARACETAMOL) for the domestic market, is today a renowned and leading supplier of 150+ niche drugs for marquee global customers.Trusted by customers worldwide, we are today, the only organisation in the world to have a USFDA certified facility for the manufacturing of Folic Acid - a product par excellence

Post : Formulation Analytical Research And Development

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies. We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have significant worldwide presence in specialty therapeutic areas such as cardiology, neurology, diabetology, etc. We have also plans for expansion in Ophthalmic etc.

Ind Swift Laboratories Ltd. Established in 1995 Ind-Swift has fast evolved towards a business model that is focused on deep-rooted domestic presence and leveraged on high-value mature regulated markets along with considerable growth in emerging markets.

Post : Executive / Asst. Manager - IPR

Coral Drugs, headquartered in New Delhi, India, is an integrated, research-based international pharmaceutical company that produces a wide range of high-quality, affordable active drug ingredients.
With a team of dedicated scientists, Coral's R&D department provides efficient processes for off-patent products. Our goal is to maximize on the production of active ingredients by discovering new ways to manufacture, without compromising quality. Having clients all over the world, we assume a great level of corporate responsibility. Adhering to quality production standards across the globe, Coral Drugs takes pride in being a true international supplier of high-quality pharmaceuticals.

Post : Officer/Executive – Quality Assurance

4th largest generic pharmaceutical company globally by market capitalization with USD 2.55 billion in revenue is looking for bright professionals with proven track record for their unit at Tarapur, MAHARASHTRA.

Post : Officer/Sr.Officer/Executive/Sr.Executive

Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

Post : Marketing Manager

Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world. We provide high- quality. affordable medicine trusted by healthcare professionals and patients in over 150 countries. It is also India's largest, most trusted and most valuable pharmaceutical company by market capitalization

The flagship company of the Piramal Group, Piramal Enterprises Ltd. (PEL), has business interests in Pharma, Information Management, and Financial Services verticals of the group.  Towards the late 80s, we shifted our focus from textile to pharmaceuticals. We chose to invest significantly in the domestic formulation development business, while other companies in the industry concentrated on international generics. Our efforts proved successful with a track record of approximately 23% revenue CAGR. In 2010, our strategy accomplished a sale of its domestic formulations business at an unprecedented value of ~9x sales and ~30x EBITDA.